Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.52 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.52 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18960495 | 0.88 | GABRA1 (0.45) | GABRA1GABRB1NLRP3 | |
| SCHEMBL13485112 | 0.79 | GABRA1 (0.54) | GABRA1GABRB1NLRP3CA1CA2 | |
| SCHEMBL14753734 | 0.79 | GABRA1 (0.45) | GABRA1CA1CA2 | |
| SCHEMBL21962997 | 0.77 | CA1 (0.30) | CA1CA2 | |
| SCHEMBL31248724 | 0.75 | GABRA1 (0.45) | GABRA1GABRB1NLRP3 | |
| SCHEMBL27501520 | 0.74 | GABRA1 (0.48) | GABRA1GABRB1NLRP3 | |
| SCHEMBL636376 | 0.73 | GABRA1 (0.58) | GABRA1GABRB1CA1CA2 | |
| SCHEMBL20681258 | 0.72 | GABRA1 (0.64) | GABRA1GABRB1NLRP3CA1CA2 | |
| SCHEMBL3206761 | 0.71 | GABRA1 (0.48) | GABRA1GABRB1NLRP3CA1CA2 | |
| Bromide SCHEMBL9491638 | 0.71 | GABRA1 (0.56) | GABRA1GABRB1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170166599-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-06-15 | — | — | US | disclosed |
| EP-3168223-A1 | METAL COMPLEX AND LIGHT EMITTING ELEMENT USING SAME | Sumitomo Chemical Company, Limited (JP) | 2017-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170166599-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE USING THE SAME | CRY1, AP2M1, CCNE2 | GABRA1 2520/4885GABRB1 2915/4885NLRP3 2015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.